KICS
MCID: KSH003
MIFTS: 16

Kshv Inflammatory Cytokine Syndrome (KICS)

Categories: Rare diseases

Aliases & Classifications for Kshv Inflammatory Cytokine Syndrome

MalaCards integrated aliases for Kshv Inflammatory Cytokine Syndrome:

Name: Kshv Inflammatory Cytokine Syndrome 52
Kics 52

Classifications:



Summaries for Kshv Inflammatory Cytokine Syndrome

MalaCards based summary : Kshv Inflammatory Cytokine Syndrome, also known as kics, is related to kaposi sarcoma and castleman disease. The drugs Zidovudine and Valganciclovir have been mentioned in the context of this disorder. Affiliated tissues include kidney, heart and t cells.

Related Diseases for Kshv Inflammatory Cytokine Syndrome

Diseases related to Kshv Inflammatory Cytokine Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 17)
# Related Disease Score Top Affiliating Genes
1 kaposi sarcoma 10.3
2 castleman disease 10.3
3 multicentric castleman disease 10.2
4 cytokine deficiency 10.2
5 lymphoma aids related 10.2
6 hair whorl 10.1
7 human herpesvirus 8 10.1
8 atrial fibrillation 10.1
9 sarcoma 10.1
10 thrombocytopenia 10.1
11 vascular disease 10.1
12 ischemia 10.1
13 spindle cell sarcoma 10.1
14 kidney disease 10.1
15 congestive heart failure 10.1
16 chronic kidney disease 10.1
17 thrombocytopenia 6 10.1

Graphical network of the top 20 diseases related to Kshv Inflammatory Cytokine Syndrome:



Diseases related to Kshv Inflammatory Cytokine Syndrome

Symptoms & Phenotypes for Kshv Inflammatory Cytokine Syndrome

Drugs & Therapeutics for Kshv Inflammatory Cytokine Syndrome

Drugs for Kshv Inflammatory Cytokine Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Zidovudine Approved Phase 2 30516-87-1 35370
2
Valganciclovir Approved, Investigational Phase 2 175865-60-8 64147
3
Ganciclovir Approved, Investigational Phase 2 82410-32-0 3454
4 Anti-Retroviral Agents Phase 2
5 Antiviral Agents Phase 2
6 Reverse Transcriptase Inhibitors Phase 2
7 Ganciclovir triphosphate Phase 2
8 Antimetabolites Phase 2
9 Anti-HIV Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS) Incorporating Pilot Evaluation of KSHV Targeted Therapies Recruiting NCT01419561 Phase 2 Zidovudine;Liposomal Doxorubicin;Valganiclovir;Rituximab
2 Phase I/II Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas (Primary Effusion Lymphoma and Large Cell Lymphoma Arising in KSHV-Associated Multicentric Castleman Disease) Withdrawn NCT02228512 Phase 1, Phase 2 Pomalidomide;Rituximab;Prednisone;Etoposide;Doxorubicin;Vincristine;Cyclophosphamide
3 A Phase 1 Trial of Pomalidomide in Combination With Liposomal Doxorubicin in Patients With Advanced or Refractory Kaposi Sarcoma Recruiting NCT02659930 Phase 1 liposomal doxorubicin;pomalidomide

Search NIH Clinical Center for Kshv Inflammatory Cytokine Syndrome

Genetic Tests for Kshv Inflammatory Cytokine Syndrome

Anatomical Context for Kshv Inflammatory Cytokine Syndrome

MalaCards organs/tissues related to Kshv Inflammatory Cytokine Syndrome:

40
Kidney, Heart, T Cells, Liver, Myeloid, Endothelial

Publications for Kshv Inflammatory Cytokine Syndrome

Articles related to Kshv Inflammatory Cytokine Syndrome:

(show top 50) (show all 52)
# Title Authors PMID Year
1
Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels. 61
31629226 2020
2
Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF). 61
31857312 2019
3
Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. 61
31102440 2019
4
A Cluster Analysis of the Japanese Multicenter Outpatient Registry of Patients With Atrial Fibrillation. 61
31350002 2019
5
The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa. 61
31004430 2019
6
Direct Structure-Performance Comparison of All-Carbon Potassium and Sodium Ion Capacitors. 61
31380159 2019
7
Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation. 61
30924896 2019
8
Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis. 61
30523620 2019
9
[Opportunistic infections: What's new?] 61
30508854 2018
10
Characteristics and in-hospital outcomes in young patients presenting with acute coronary syndrome treated by percutaneous coronary intervention. 61
28585049 2018
11
Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection. 61
29896675 2018
12
The impact of a head and neck microvascular fellowship program on otolaryngology resident training. 61
28602040 2018
13
Successful Treatment of Kaposi Sarcoma-Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney-Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response. 61
28489271 2017
14
Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry. 61
29079567 2017
15
HIV-associated Kaposi sarcoma and related diseases. 61
28609402 2017
16
Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition. 61
28424322 2017
17
Barriers Associated With Door-to-Balloon Delay in Contemporary Japanese Practice. 61
28228609 2017
18
Kids in Communities Study (KiCS) study protocol: a cross-sectional mixed-methods approach to measuring community-level factors influencing early child development in Australia. 61
28289049 2017
19
Monitoring Nonlinear and Non-Gaussian Processes Using Gaussian Mixture Model-Based Weighted Kernel Independent Component Analysis. 61
26685274 2017
20
Incidence and predictors of bleeding complications after percutaneous coronary intervention. 61
27269413 2017
21
Clinical outcomes of percutaneous coronary intervention for acute coronary syndrome between hospitals with and without onsite cardiac surgery backup. 61
26928574 2017
22
Kaposi sarcoma herpesvirus-associated cancers and related diseases. 61
27662501 2017
23
Experience with Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome in a Large Urban HIV Clinic in the United States: Case Series and Literature Review. 61
29766014 2017
24
Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome. 61
28845155 2017
25
AQP2 Plasma Membrane Diffusion Is Altered by the Degree of AQP2-S256 Phosphorylation. 61
27801846 2016
26
[Kaposi's Sarcoma Herpesvirus-associated Inflammatory Cytokine Syndrome (KICS) Improved by Antiretroviral Therapy in an HIV-infected Patient]. 61
30212041 2016
27
Assessing Nursing Care Needs of Children With Complex Medical Conditions: The Nursing-Kids Intensity of Care Survey (N-KICS). 61
26777429 2016
28
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). 61
26658701 2016
29
An Intermittent Model for Intracellular Motions of Gold Nanostars by k-Space Scattering Image Correlation. 61
26636936 2015
30
An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS). 61
26678628 2015
31
Relation between stent thrombosis and calcium channel blocker after drug-eluting stent implantation: Kumamoto Intervention Conference Study (KICS) registry. 61
25572022 2015
32
A high fat diet containing saturated but not unsaturated fatty acids enhances T cell receptor clustering on the nanoscale. 61
26143085 2015
33
Get your kICS by measuring membrane protein dynamics. 61
26153695 2015
34
KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies. 61
24771491 2015
35
Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo. 61
25607954 2015
36
Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation - The Kumamoto Intervention Conference Study (KICS) Registry. 61
25739954 2015
37
Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry. 61
25874887 2015
38
Measuring localization and diffusion coefficients of basolateral proteins in lateral versus basal membranes using functionalized substrates and kICS analysis. 61
24950246 2014
39
Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings. 61
25019430 2014
40
Easy measurement of diffusion coefficients of EGFP-tagged plasma membrane proteins using k-Space Image Correlation Spectroscopy. 61
24893770 2014
41
Measuring ligand-receptor binding kinetics and dynamics using k-space image correlation spectroscopy. 61
23938869 2014
42
Elevated cAMP increases aquaporin-3 plasma membrane diffusion. 61
24452376 2014
43
Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. 61
23770181 2013
44
Image correlation spectroscopy: mapping correlations in space, time, and reciprocal space. 61
23276542 2013
45
Bridging the gap between single molecule and ensemble methods for measuring lateral dynamics in the plasma membrane. 61
24324577 2013
46
Vironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6A. 61
22925337 2012
47
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome. 61
22448005 2012
48
Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome. 61
22403576 2012
49
Europe's innovation hub finally KICs off. 61
21350459 2011
50
Advances in image correlation spectroscopy: measuring number densities, aggregation states, and dynamics of fluorescently labeled macromolecules in cells. 61
17952641 2007

Variations for Kshv Inflammatory Cytokine Syndrome

Expression for Kshv Inflammatory Cytokine Syndrome

Search GEO for disease gene expression data for Kshv Inflammatory Cytokine Syndrome.

Pathways for Kshv Inflammatory Cytokine Syndrome

GO Terms for Kshv Inflammatory Cytokine Syndrome

Sources for Kshv Inflammatory Cytokine Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....